Our study reveals that HIV-associated lymphomas display distinct molecular and clinicopathologic characteristics, including a high rate of EBV infection, a predominant GCB phenotype, and a paradoxical profile of high proliferative activity coupled with low BCL2 expression. This evidence concerns the gene BCL2 and Epstein-Barr virus infection.